[Federal Register Volume 63, Number 33 (Thursday, February 19, 1998)]
[Rules and Regulations]
[Page 8349]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-4081]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
21 CFR Parts 526 and 529
Animal Drugs, Feeds, and Related Products; Cephapirin Sodium for
Intramammary Infusion; Redesignation
AGENCY: Food and Drug Administration, HHS.
ACTION: Final rule.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is amending the animal
drug regulations to redesignate a section of those regulations. A
section reflecting approval of an intramammary product is redesignated
from certain other dosage form new animal drugs to intramammary dosage
forms to reflect the correct designation of the product.
EFFECTIVE DATE: February 19, 1998.
FOR FURTHER INFORMATION CONTACT: David L. Gordon, Center for Veterinary
Medicine (HFV-6), Food and Drug Administration, 7500 Standish Pl.,
Rockville, MD 20855, 301-594-1739.
SUPPLEMENTARY INFORMATION: The animal drug regulations in part 529 (21
CFR part 529) provide for codification of certain other dosage form new
animal drugs. The regulations in part 526 (21 CFR part 526) provide for
codification of intramammary dosage forms. Cephapirin sodium for
intramammary infusion was inadvertently codified as Sec. 529.365. At
this time, the animal drug regulations are amended to redesignate
Sec. 529.365 as Sec. 526.365.
List of Subjects
21 CFR Parts 526 and 529
Animal drugs.
Therefore, under the Federal Food, Drug, and Cosmetic Act and under
the authority delegated to the Commissioner of Food and Drugs and
redelegated to the Center for Veterinary Medicine, 21 CFR parts 526 and
529 are amended as follows:
PART 526--INTRAMAMMARY DOSAGE FORMS
PART 529--CERTAIN OTHER DOSAGE FORM NEW ANIMAL DRUGS
1. The authority citations for 21 CFR parts 526 and 529 continue to
read as follows:
Authority: 21 U.S.C. 360b.
Sec. 529.365 [Redesignated as Sec. 526.365]
2. Section 529.365 is redesignated as Sec. 526.365.
Dated: February 5, 1998.
Andrew J. Beaulieau,
Deputy Director, Office of New Animal Drug Evaluation, Center for
Veterinary Medicine.
[FR Doc. 98-4081 Filed 2-18-98; 8:45 am]
BILLING CODE 4160-01-F